Posted: January 9, 2018
Invokana (or Invokamet or Invokamet XR), is associated with an elevated risk of amputation of the leg, foot and toes. In fact, the FDA has updated the warnings on these medications to reflect the risk. These medications are sodium-glucose cotransporter 2 (SGLT2) inhibitors, drugs used to treat Type II diabetes.